ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Animal models"

  • Abstract Number: 2072 • 2018 ACR/ARHP Annual Meeting

    Beneficial Effect of Combination Therapy of Etanercept with Non-Steroidal Anti-Inflammatory Drugs Compared to Etanercept Monotherapy in a Spondyloarthritis Animal Model

    Seung-Cheol Shim1, Ji-Young Kim2, Seung Taek Song3, Jin-Sun Choi2, Chan Keol Park4 and In-Seol Yoo1, 1Division of Rheumatology, Department of Internal Medicine, Daejeon Rheumatoid & Degenerative Arthritis Center, Chungnam National University Hospital, Daejeon, Korea, Republic of (South), 2Division of Rheumatology, Daejeon Rheumatoid & Degenerative Arthritis Center, Chungnam National University Hospital, Daejeon, Korea, Republic of (South), 3Department of Rheumatology, Cheongju St. Mary's Hospital, Cheongju, Korea, Republic of (South), 4Internal medicine, Daejeon Rheumatoid & Degenerative Arthritis Center, Chungnam National University Hospital, Daejeon, Korea, Republic of (South)

    Background/Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended as first-line drug treatment of  spondyloarthritis (SpA) which is frequently associated with inflammatory bowel disease. Biologic disease modifying…
  • Abstract Number: 1007 • 2018 ACR/ARHP Annual Meeting

    Macrophage Mediators of Autoimmune Valvular Carditis and Fibrosis

    Lee Meier1, Mayra Gonzalez-Torres2, Jennifer L. Auger2, Aubyn Marath3 and Bryce A. Binstadt2, 1Department of Pediatrics and Center for Immunology, University of Minnesota, Minneapols, MN, 2Department of Pediatrics and Center for Immunology, University of Minnesota, Minneapolis, MN, 3CardioStart International, Tampa, FL

    Background/Purpose: K/B.g7 TCR transgenic mice spontaneously develop both autoimmune arthritis and valvular carditis. We utilize this model to define mediators of rheumatic disease-associated cardiovascular inflammation…
  • Abstract Number: 2077 • 2018 ACR/ARHP Annual Meeting

    Pathological Osteogenesis and Inflammation in Experimental Spondyloarthritis Are Associated with Aberrant Type H Blood Vessels and Development of High Endothelial Venules Accompanied By Ectopic Lymphoid Structures in Bone Marrow

    Merlijn Kaaij1, Jan Piet van Hamburg2, George Kollias3, Dominique Baeten1, Leonie van Duivenvoorde1 and Sander W. Tas2, 1Department of Clinical Immunology & Rheumatology and Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Amsterdam Rheumatology & immunology Center | Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 3Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece

    Background/Purpose: Spondyloarthritis (SpA) is characterized by pathological osteogenesis, inflammation and extensive angiogenesis in inflamed tissues. TNF plays a central role in SpA pathology and transgenic…
  • Abstract Number: 1021 • 2018 ACR/ARHP Annual Meeting

    Impact of TLR7 Ligation in RA Pathology

    Sadiq Umar1,2, Katrien Van Raemdonck1,2, Karol Palasiewicz1,2 and Shiva Shahrara1, 1Medicine, Division of Rheumatology, University of Illinois at Chicago, Chicago, IL, 2Jesse Brown VA Medical Center, Chicago, IL

    Background/Purpose: Expression of Toll-like receptor 7 (TLR-7) is highly elevated in rheumatoid arthritis (RA) and osteoarthritis (OA) compared to normal (NL) synovial tissue lining and…
  • Abstract Number: 2082 • 2018 ACR/ARHP Annual Meeting

    ERAP1 Deficiency Partially Relieves HLA-B27-Induced ER Stress and IL-23 Expression, but Does Not Restore Dendritic Cell Function in Experimental Spondyloarthritis

    Tri Tran1, Vance Holt2, Tejpal Gill1, Joshua R. Bennett2, Joel Taurog3 and Robert Colbert4, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3Dept Int Med-Rheum Dis Div, University of Texas Southwestern Medical Center, Dallas, TX, 4National Institute of Arthritis and Musculuskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

    Background/Purpose: Preliminary results suggest that endoplasmic reticulum (ER) aminopeptidase 1 (ERAP1) deficiency partially protects HLA-B27/human b2m transgenic (B27-Tg) rats from spondyloarthritis (SpA) as evidenced by…
  • Abstract Number: 1033 • 2018 ACR/ARHP Annual Meeting

    Comparison of Oral Administration of Diacerein, Intra-Articular Injection of Diacerein Solution, and Intra-Articular Injection of Diacerein-Loaded Nanoparticle in Osteoarthritis Rat Model

    Jae Hyun Jung1,2, Sung Jae Choi1,3, Gwan Gyu Song1,2, Sung Eun Kim4 and Hak-Jun Kim5,6, 1Internal Medicine, Korea University College of Medicine, Seoul, Korea, Republic of (South), 2Internal Medicine, Korea University Guro Hospital, Seoul, Korea, Republic of (South), 3Internal Medicine, Korea University Ansan Hospital, Ansan, Korea, Republic of (South), 4Orthopedic Surgery, Korea University Guro Hospitial, Seoul, Korea, Republic of (South), 5Orthopedic Surgery, Korea Univertisy College of Medicine, Seoul, Korea, Republic of (South), 6Orthopedic Surgery, Korea University Guro Hospital, Seoul, Korea, Republic of (South)

    Background/Purpose: Osteoarthritis (OA) treatment is typically administered to control symptoms. Diacerein (DIA) reduces interleukin (IL)-1 receptor on chondrocytes and prevents structural degradation of joint tissue.…
  • Abstract Number: 2090 • 2018 ACR/ARHP Annual Meeting

    Identification of a Role for Monocytes in Murine Lupus Associated Diffuse Alveolar Hemorrhage By Mass Cytometry

    Nathan Nelson-Maney1, Pui Lee2, Anais Levescot3, Yuelong Huang4 and Peter Nigrovic5, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, boston, MA, 4Brigham and Women's Hospital, Boston, MA, 5Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Diffuse alveolar hemorrhage (DAH) is a life-threatening pulmonary complication of systemic lupus erythematosus. The inciting pathology is thought to be pulmonary capillaritis but the…
  • Abstract Number: 1034 • 2018 ACR/ARHP Annual Meeting

    A Conplastic Mice Model of Aging Reveals That Mitochondrial DNA Variation Influences the Process of Joint Deterioration

    Ignacio Rego-Pérez1, Ana Victoria Lechuga-Vieco2, Morena Scotece1, Purificación Filgueira-Fernández1, Sonia Pertega3, Jose Antonio Enríquez2 and Francisco J Blanco4, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña. España, A Coruña, Spain, 2Grupo de Genética funcional del sistema de fosforilación oxidativa. Centro Nacional de Investigaciones Cardiovasculares (CNIC). C/Melchor Fernández de Almagro, 3, 2 Sur. 28029. Madrid, España, Madrid, Spain, 3Unidad de Epidemiología Clínica y Bioestadística. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain, 4Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain

    Background/Purpose: Different studies showed interesting genetic associations between mtDNA haplogroups and OA-related features, including prevalence, incidence and progression of the disease. The aim of this…
  • Abstract Number: 2096 • 2018 ACR/ARHP Annual Meeting

    Ectonucleotidase CD73 Suppresses Autoantibody Production and Arterial Vasculopathy in Murine Lupus

    Ramadan A. Ali1, Nicole R. Pearce1, Srilakshmi Yalavarthi1, Kevin B. Atkins1, Alex A. Gandhi1, Yogendra Kanthi1 and Jason S. Knight2, 1University of Michigan, Ann Arbor, MI, 2., University of Michigan, Ann Arbor, MI

    Background/Purpose: CD73 is a surface nucleotidase that extends into the extracellular space where it generates adenosine from AMP. By regulating a cell’s “purinergic halo,” CD73…
  • Abstract Number: 1039 • 2018 ACR/ARHP Annual Meeting

    Tenofovir Induces Osteopenia and Dipyridamole, an Inhibitor of the Ent-1 Nucleoside Transporter, Reverses the Osteopenic Effect of Tenofovir In Vivo

    Francisco Miguel Conesa-Buendia1, Patricia Llamas2, Tuere Wilder3, Raquel Largo4, Gabriel Herrero-Beaumont4, Bruce N. Cronstein5 and Aranzazu Mediero6, 1Bone and Joint Research Unit, IIS-Fundacion Jimenez Diaz- UAM, Madrid, Spain, 2Bone and Joint Research Unit, IIS-Fundacion Jimenez Díaz-UAM, Madrid, Spain, 3Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 4Bone and Joint Research Unit, Fundación Jiménez Díaz University Hospital & Health Research Institute, Madrid, Spain, 5Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY, 6Joint and Bone Research Unit, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain

    Background/Purpose: Osteopenia and fragility fractures have been associated with HIV infection. Tenofovir, one of the most commonly used antivirals in HIV, also leads to increases…
  • Abstract Number: 2103 • 2018 ACR/ARHP Annual Meeting

    Using a Drosophila Model to Unravel the Genetic Complexity of Systemic Lupus Erythematosus

    Nathan Mortimer, Mary Fischer, Ashley Waring and Victoria DeMichel, School of Biological Sciences, Illinois State University, Normal, IL

    Background/Purpose: The objective of our research is to understand the genetic architecture and molecular mechanisms that contribute to the development and progression of the autoimmune…
  • Abstract Number: 38 • 2018 ACR/ARHP Annual Meeting

    Pre-Clinical Clonally-Expanded aggrecan89-103–Specific CD4+ T Cells Are a Target for Autoimmune Arthritis Prevention

    Pascale Wehr1, Hendrik Nel1, Soi Cheng Law1, Diahann Jansen1, Nicole La Gruta2, Hugh Reid2, Jamie Rossjohn2 and Ranjeny Thomas1, 1University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Australia, 2Infection and Immunity Program, Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia

    Background/Purpose: In the pre-clinical rheumatoid arthritis (RA) prodrome, autoantibodies and transient symptoms may develop. Pre-clinical autoantibody development suggests concomitant expansion of autoantigen-specific CD4+ follicular helper…
  • Abstract Number: 1076 • 2018 ACR/ARHP Annual Meeting

    Phospholipase C-eta2, As a C2 Domain-Containing Protein, Regulate Aggressiveness of Fibroblast‐like Synoviocytes and Ameliorate Arthritis in Experimental Animal Models of Rheumatoid Arthritis

    Mingyo Kim, Hyun Min Jeon, Hae Sook Noh, Sang Mi Yi and Sang-Il Lee, Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea, Republic of (South)

    Background/Purpose: The C2 domain is a Ca2+-dependent membrane-targeting motif found in many cellular proteins involved in signal transduction or inflammatory pathway. However, the effects of…
  • Abstract Number: 2451 • 2018 ACR/ARHP Annual Meeting

    Herpes Zoster in Rheumatoid Arthritis. Prospective Single Center Study of 390 RA Patients for 5 YEARS

    Lucia C. Domínguez-Casas1, Vanesa Calvo-Río2, Paz Rodríguez-Cundín3, Virginia Portilla4, Nuria Vegas-Revenga2, F. Antolin5, M. Rebollo-Rodrigo3, Alfonso Corrales1, Diana Prieto Peña2, Monica Calderón Goercke2, Miguel Angel González-Gay6 and Ricardo Blanco1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 2Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 3Preventive Medicine, Preventive Medicine. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain., Santander, Spain, 4Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 5Preventive Medicine. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain., Santander, Spain, 6Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain

    Background/Purpose: Immunosuppressed patients such as Rheumatoid Arthritis (RA) patients have a greater risk (1.5-2 times) of presenting herpes zoster (HZ). Both, the disease itself and…
  • Abstract Number: 39 • 2018 ACR/ARHP Annual Meeting

    Allogeneic Mesenchymal Stem Cells Derived Extracellular Vesicles As a Superior Immunosuppressant in Murine Arthritis Therapy

    Runci Wang1,2, Yi Liu3,4 and Songtao Shi5, 1Department of Anatomy and cell biology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, 2Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China, 3Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Chengdu, China, 4Department of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, China, 5Department of Anatomy and Cell Biology, School of Dental Medicine, University of Pennsylvania,, Philadelphia, PA

    Allogeneic mesenchymal stem cells derived extracellular vesicles as a superior immunosuppressant in murine arthritis therapyRunci Wang1,2, Yi Liu2, Songtao Shi1Affiliation: 1. Department of Anatomy and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology